Progress on the Therapeutic Approaches for Malignant Tumor with Superior Vena Cava Syndrome
Patients with thoracic malignant tumors often suffered from superior vena cava syndrome (SVCS), featured by high morbidity and mortality. Traditionally treated with palliative approaches, SVCS has been widely studied and novel therapeutic approaches have been investigated, focusing on drug therapy, interventional therapy, radiation therapy, surgery and proton therapy. In this manuscript, the progress of therapeutic approaches for SVCS is summarized. DOI: 10.3779/j.issn.1009-3419.2016.11.11
Source: Chinese Journal of Lung Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Cardiovascular & Thoracic Surgery | Lung Cancer | Palliative | Palliative Care | Proton Therapy | Radiation Therapy